| SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research SPARK Consortium Neuron 97 (3), 488-493, 2018 | 308* | 2018 |
| High-resolution expression map of the Arabidopsis root reveals alternative splicing and lincRNA regulation S Li, M Yamada, X Han, U Ohler, PN Benfey Developmental cell 39 (4), 508-522, 2016 | 270 | 2016 |
| Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient … A Oaknin, L Gilbert, AV Tinker, J Brown, C Mathews, J Press, R Sabatier, ... Journal for immunotherapy of cancer 10 (1), 2022 | 188 | 2022 |
| Unique cell-type-specific patterns of DNA methylation in the root meristem T Kawakatsu, T Stuart, M Valdes, N Breakfield, RJ Schmitz, JR Nery, ... Nature plants 2 (5), 1-8, 2016 | 179 | 2016 |
| Analysis of Arabidopsis genome-wide variations before and after meiosis and meiotic recombination by resequencing Landsberg erecta and all four products of a single meiosis P Lu, X Han, J Qi, J Yang, AJ Wijeratne, T Li, H Ma Genome Research 22 (3), 508-518, 2012 | 153 | 2012 |
| RGF1 controls root meristem size through ROS signalling M Yamada, X Han, PN Benfey Nature 577 (7788), 85-88, 2020 | 147 | 2020 |
| Transcriptome of embryonic and neonatal mouse cortex by high-throughput RNA sequencing X Han, X Wu, WY Chung, T Li, A Nekrutenko, NS Altman, G Chen, H Ma Proceedings of the National Academy of Sciences 106 (31), 12741-12746, 2009 | 101 | 2009 |
| Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors W Fu, H Lan, S Li, X Han, T Gao, D Ren Cancer Gene Therapy 15 (7), 474-484, 2008 | 57 | 2008 |
| Synergistic antitumoral effects of human telomerase reverse transcriptase‐mediated dual‐apoptosis‐related gene vector delivered by orally attenuated Salmonella enterica Serovar … W Fu, L Chu, X Han, X Liu, D Ren The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008 | 43 | 2008 |
| Distinct epigenomic patterns are associated with haploinsufficiency and predict risk genes of developmental disorders X Han, S Chen, E Flynn, S Wu, D Wintner, Y Shen Nature communications 9 (1), 2138, 2018 | 35 | 2018 |
| Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy I Lodewijk, A Bernardini, C Suárez-Cabrera, E Bernal, R Sánchez, ... NPJ Precision Oncology 6 (1), 7, 2022 | 13 | 2022 |
| O007/# 456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer … A Tinker, R Sabatier, A Gravina, L Gilbert, J Brown, V Samouëlian, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | 6 | 2022 |
| Root meristem growth factor 1 controls root meristem size through reactive oxygen species signaling M Yamada, X Han, PN Benfey bioRxiv, 244947, 2018 | 6 | 2018 |
| 76P Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial A Oaknin, L Gilbert, A Tinker, J Brown, C Mathews, JZ Press, R Sabatier, ... Annals of Oncology 32, S388-S389, 2021 | 5 | 2021 |
| Antitumor activity of dostarlimab by PD-L1 and tumor mutation burden (TMB) in patients (pts) with mismatch repair deficient and proficient (dMMR and MMRp) tumors in the GARNET … T Andre, S Banerjee, D Berton, SL Ellard, B Jimenez, V Samouelian, ... Cancer Research 82 (12_Supplement), 5135-5135, 2022 | 3 | 2022 |
| Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2. PJ Keller, R Meyer, E Greenwald, X Han, AR Conery, JA Mertz, P Trojer CLINICAL CANCER RESEARCH 26 (15), 40-40, 2020 | 2 | 2020 |
| RNA: an expanding view of function and evolution X Han, Y Chen, L Wang, W Fang, N Zhang, Q Zhu Evolutionary Bioinformatics 11, EBO. S38105, 2015 | 1 | 2015 |
| Antitumor activity of dostarlimab by PD-L1 and tumor mutation burden (TMB) in patients (pts) with mismatch repair deficient and proficient (dMMR and MMRp) tumors in the GARNET … A Vogel, T Andre, S Banerjee, D Berton, SL Ellard, B Jimenez, ... ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 3), 17-17, 2022 | | 2022 |
| 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study AV Tinker, B Pothuri, L Gilbert, R Sabatier, J Brown, S Ghamande, ... International Journal of Gynecologic Cancer 32 (Suppl 2), 2022 | | 2022 |
| 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial S Banerjee, T André, D Berton, SL Ellard, B Jimenez, V Samouëlian, ... International Journal of Gynecological Cancer 32 (Suppl 2), A410-A410, 2022 | | 2022 |
Ji QiProfessor of Computational Biology, Fudan UniversityAdresse e-mail validée de fudan.edu.cn
